281 related articles for article (PubMed ID: 7527668)
1. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
Miura O; Miura Y; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Dec; 84(12):4135-41. PubMed ID: 7527668
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
4. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
5. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.
Miura Y; Miura O; Ihle JN; Aoki N
J Biol Chem; 1994 Nov; 269(47):29962-9. PubMed ID: 7961995
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
[TBL] [Abstract][Full Text] [Related]
7. CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.
Arai A; Kanda E; Nosaka Y; Miyasaka N; Miura O
J Biol Chem; 2001 Aug; 276(35):33282-90. PubMed ID: 11443118
[TBL] [Abstract][Full Text] [Related]
8. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
10. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.
Witthuhn BA; Quelle FW; Silvennoinen O; Yi T; Tang B; Miura O; Ihle JN
Cell; 1993 Jul; 74(2):227-36. PubMed ID: 8343951
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.
Machide M; Mano H; Todokoro K
Oncogene; 1995 Aug; 11(4):619-25. PubMed ID: 7651724
[TBL] [Abstract][Full Text] [Related]
12. Activated Ki-Ras complements erythropoietin signaling in CTLL-2 cells, inducing tyrosine phosphorylation of a 160-kDa protein.
Yamamura Y; Noda M; Ikawa Y
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8866-70. PubMed ID: 7522324
[TBL] [Abstract][Full Text] [Related]
13. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity.
Shigematsu H; Iwasaki H; Otsuka T; Ohno Y; Arima F; Niho Y
J Biol Chem; 1997 May; 272(22):14334-40. PubMed ID: 9162069
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
15. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
Ueda F; Tago K; Tamura H; Funakoshi-Tago M
J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
[TBL] [Abstract][Full Text] [Related]
16. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction.
Gobert S; Porteu F; Pallu S; Muller O; Sabbah M; Dusanter-Fourt I; Courtois G; Lacombe C; Gisselbrecht S; Mayeux P
Blood; 1995 Jul; 86(2):598-606. PubMed ID: 7541671
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway.
He TC; Jiang N; Zhuang H; Wojchowski DM
J Biol Chem; 1995 May; 270(19):11055-61. PubMed ID: 7538110
[TBL] [Abstract][Full Text] [Related]
19. Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors.
Ghaffari S; Kitidis C; Fleming MD; Neubauer H; Pfeffer K; Lodish HF
Blood; 2001 Nov; 98(10):2948-57. PubMed ID: 11698276
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic signaling and inhibition of apoptosis via the erythropoietin receptor Box-1 domain.
Joneja B; Wojchowski DM
J Biol Chem; 1997 Apr; 272(17):11176-84. PubMed ID: 9111017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
